5-methylcytosine has been researched along with Parkinson Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Han, J; Jin, P; Li, Y; Li, Z; Min, S; Qin, L; Tang, B; Wu, H; Xu, Q; Zhu, X | 1 |
| Chen, JL; Chen, TJ; Chen, YJ; Feng, Y; Li, Q; Li, X; Liu, T; Liu, Y; Wu, TT; Wu, YC; Zhu, XY | 1 |
| Kaut, O; Kuchelmeister, K; Moehl, C; Wüllner, U | 1 |
| Lei, X; Lv, Q; Yin, X; Zhang, B; Zheng, T | 1 |
4 other study(ies) available for 5-methylcytosine and Parkinson Disease
| Article | Year |
|---|---|
Altered hydroxymethylome in the substantia nigra of Parkinson's disease.
Topics: 5-Methylcytosine; alpha-Synuclein; DNA Methylation; Epigenesis, Genetic; Humans; Parkinson Disease; Phospholipase D; Substantia Nigra | 2022 |
TET2-mediated Cdkn2A DNA hydroxymethylation in midbrain dopaminergic neuron injury of Parkinson's disease.
Topics: 5-Methylcytosine; Animals; Cyclin-Dependent Kinase Inhibitor p16; Dioxygenases; Disease Models, Animal; DNA Methylation; DNA-Binding Proteins; Dopaminergic Neurons; Epigenesis, Genetic; Humans; Male; Mesencephalon; Mice; Parkinson Disease; Proto-Oncogene Proteins | 2020 |
5-methylcytosine and 5-hydroxymethylcytosine in brains of patients with multiple system atrophy and patients with Parkinson's disease.
Topics: 5-Methylcytosine; Aged; Aged, 80 and over; Brain; Female; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease | 2019 |
Spatial distribution of 5-hydroxymethyl cytosine in rat brain and temporal distribution in striatum.
Topics: 5-Methylcytosine; Animals; Brain; Corpus Striatum; Cytosine; Male; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley | 2015 |